1ProLynx LOGO.png
ProLynx announces publication and initiation of patient recruitment for a trial of once-monthly treatment of diabetes in cats
September 05, 2019 09:00 ET | ProLynx LLC
SAN FRANCISCO, Sept. 05, 2019 (GLOBE NEWSWIRE) -- Today, ProLynx announced publication of data supporting therapy of Type 2 diabetes in cats with PLX039, a GLP-1 receptor agonist that can be...